NASDAQ:FBIO

Fortress Biotech Earning Date

USA |NASDAQ |USD

FBIO Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 8, 2021 Sep 2021 $-0.08 $-0.04 $-0.20
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 8, 2021 Sep 2021 $18.42M $17.84M $9.47M

Fortress Biotech's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 2021.

FBIO Earnings Date & History Chart

FBIO Earnings & Revenue Forecast

FBIO Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 6 $-0.08 $-0.15 $0.09
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 6 $-0.32 $-0.47 $0.00
Dec 2022 6 $0.10 $-1.01 $1.14

FBIO Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.08 $-0.13 $-0.13
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.32 $-0.50 $-0.50
Dec 2022 0 / 0 $0.10 $0.06 $0.06

FBIO Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 6 $19.95M $15.15M $22.50M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 6 $67.78M $59.73M $71.80M
Dec 2022 6 $103.03M $24.15M $205.30M

FBIO Earnings Date & Revenue History

FBIO Earnings History

|
Show More
Show More

FBIO Revenue History

|
Show More
Show More

Fortress Biotech Next Earnings Date & Report

FBIO Next Earnings Date & Report Preview: Sep 2021 (FQ)

FBIO's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 6 analysts, the average EPS estimation for Fortress Biotech's next quarterly earnings is $-0.08, with a low EPS estimation of $-0.16, and a high estimation of $0.06.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.08, the last 2 month trend is $-0.13, and the 3 month trend is $-0.13.

Based on 6 analysts, the average revenue estimation is $18.42M, with a low revenue estimation of $15.15M, and a high estimation of $20.90M.

Fortress Biotech Previous Earnings Dates & Reports

FBIO Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Fortress Biotech's previous earnings date was Aug 16, 2021 for its fiscal quarter ended Jun 30, 2021.

FBIO's earnings per share (EPS) was $-0.04, beating the consensus analysts forecast of $-0.17 by 76.19%.

The EPS was higher than the previous fiscal quarter (Mar 2021) by -63.64%, and higher than the same period a year before (Jun 2020) by -78.95%.

Revenues were $17.84M, better than the forecast of $17.84M by 0.00%, up by 53.99% from the previous quarter , and up by 88.68% from the same period last year.

The company reported a net income of $-3.54M.

Free cash flow for the quarter was $-39.30M , compared to $-22.15M last quarter and $-18.48M a year before.

FBIO ended the quarter with $86.50M in total debt, a decrease of -0.97% compared to the previous quarter, and a decrease of -5.23% compared to the same quarter a year before.

FBIO Previous Earnings Date & Report Recap: Dec 2020 (FY)

Fortress Biotech's previous annual earnings date was Mar 31, 2021 for its fiscal year ended Dec 31, 2020.

FBIO's earnings per share (EPS) was $-0.64, beating the consensus analysts forecast of $-0.73 by -12.33% , and higher than the previous year's EPS (Dec 2019) by -9.86%.

Revenues were $45.60M, better than the forecast of $44.02M by 3.59%, and up by 24.49% from previous year's revenue.

The company reported a net income of $-46.53M.

Fortress Biotech reported a free cash flow of $-90.85M for its fiscal year, compared to $-104.36M a year ago.

The company ended the fiscal year with $66.19M in total debt, a decrease of -27.61% compared to the previous year.